SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-10-057246
Filing Date
2010-03-15
Accepted
2010-03-15 17:28:35
Documents
5
Period of Report
2010-03-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 18971
2 WARRANT AGREEMENT dex41.htm EX-4.1 117667
3 OPINION OF SHEPPARD, MULLIN, RICHTER & HAMPTON LLP dex51.htm EX-5.1 8754
4 PRESS RELEASE dex991.htm EX-99.1 6767
5 GRAPHIC g97096g65f05.jpg GRAPHIC 17929
  Complete submission text file 0001193125-10-057246.txt   178912
Mailing Address 12255 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 12255 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 (858) 436-1000
Cardium Therapeutics, Inc. (Filer) CIK: 0000772320 (see all company filings)

IRS No.: 840635673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33635 | Film No.: 10682714
SIC: 2836 Biological Products, (No Diagnostic Substances)